Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FBXW7 |
| Variant | E192A |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | FBXW7 E192A does not lie within any known functional domains of the Fbxw7 protein (UniProt.org). E192A has been identified in the scientific literature (PMID: 35346215, PMID: 24586741), but has not been biochemically characterized and therefore, its effect on Fbxw7 protein function is unknown (PubMed, Jun 2025). |
| Associated Drug Resistance | |
| Category Variants Paths |
FBXW7 mutant FBXW7 E192A |
| Transcript | NM_001349798.2 |
| gDNA | chr4:g.152350051T>G |
| cDNA | c.575A>C |
| Protein | p.E192A |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_033632.3 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_011532085.3 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_024454124.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_011532084.2 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_011532084 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_047415899.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_011532083 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_011532085.2 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_047415898.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_047415901.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| NM_001349798.2 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_024454123.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| NM_001349798.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_011532084.3 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_011532085 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_017008362 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_047415897.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| NM_033632.3 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_024454121.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| NM_033632 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_024454122.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_047415900.1 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| XM_024454123.2 | chr4:g.152350051T>G | c.575A>C | p.E192A | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| FBXW7 E192A | fibrolamellar carcinoma | predicted - sensitive | Sirolimus | Case Reports/Case Series | Actionable | In a Phase I study, Rapamune (sirolimus) resulted in prolonged stable disease in a patient with hepatocellular fibrolamellar carcinoma harboring FBXW7 E192A (PMID: 24586741). | 24586741 |